TC Biopharm (Holdings) Plc (TCBP)
NASDAQ: TCBP · Real-Time Price · USD
0.625
-0.005 (-0.79%)
Nov 21, 2024, 12:09 PM EST - Market open
TC Biopharm (Holdings) Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
41
Market Cap
342.54K USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | 3.84M | 1.87M | 94.30% |
Dec 31, 2021 | 1.98M | - | - |
Dec 31, 2020 | 1.98M | -1.45M | -42.26% |
Dec 31, 2019 | 3.43M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTCBP News
- 9 days ago - TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant - PRNewsWire
- 22 days ago - TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements - PRNewsWire
- 27 days ago - TCBP Responds to False Social Media Claim - PRNewsWire
- 4 weeks ago - TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic - PRNewsWire
- 7 weeks ago - TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening - PRNewsWire
- 2 months ago - TCBP Announces Site Opening of Guys and St. Thomas Hospital - PRNewsWire
- 2 months ago - TCBP to Present at the 2024 ThinkEquity Conference in NYC - PRNewsWire
- 2 months ago - TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial - PRNewsWire